InvestorsObserver
×
News Home

Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice - Contact Johnson Fistel, LLP

Thursday, April 25, 2024 03:31 PM | GlobeNewswire via QuoteMedia

Mentioned in this article

Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice – Contact Johnson Fistel, LLP

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Inari Medical, Inc. (NASDAQ: NARI) ("Inari Medical"). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Inari Medical securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws.

What if I purchased Inari Medical securities? If you believe that you may have a potential claim against Inari Medical and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471 or click here to join the investigation online. There is no cost or obligation to you.

Click Here to Join the Investigation

What is Johnson Fistel investigating? On February 28, 2024, after the closure of the market, Inari Medical publicized that they have been served with a civil investigative demand from the U.S. Department of Justice, which has launched an inquiry under the federal Anti-Kickback Statute and Civil False Claims Act in connection to particular payments extended to healthcare professionals. Following this disclosure, Inari Medical's share price fell 20.8% on February 29, 2024.

What if I have relevant nonpublic information? Individuals with nonpublic information about the Company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at (619) 814-4471 or jimb@johnsonfistel.com .

About Johnson Fistel, LLP | Top Law Firm, Securities Fraud, Investors Rights:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. We also extend our services to foreign investors who have purchased on US exchanges. Stay updated with news on stock drops and learn how Johnson Fistel, LLP can help you recover your losses. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com .

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contact:

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com


Primary Logo

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App